Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Penumbra Inc (PEN) Financials & SEC Data · SECfinAPI
Company
Penumbra Inc (PEN)
Standardized SEC financial data for Penumbra Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001321732 · NYSE · Surgical & Medical Instruments & Apparatus.
Gross margin
67.1%
Operating margin
13.5%
Net margin
12.7%
Revenue growth (YoY)
17.5%
Return on equity
12.4%
Free cash flow
$174.9M
Current ratio
6.64×
EPS (diluted)
$4.52
Ratios for fiscal year 2025, standardized from SEC filings.